Investors

Press releases

2021/11/18

Results from investigator-initiated phase II clinical study of remetinostat in patients with squamous cell carcinoma published

Read more
2021/11/11

Medivir to present at the Redeye Life Science Day

Read more
2021/11/04

Birinapant clinical study initiated by IGM Biosciences

Read more

Presentations

Quarterly report presentations

Events

2021/12/02

Erik Penser Bank - Life Science Day

Read more
2022/02/15

Year-End Report, January - December 2021

Read more
2022/04/28

Interim Report, January - March 2022

Read more

Corporate Governance

Medivir Corporate Governance documention.

Annual General Meeting

Documentation from Medivir's Annual General Meetings.